Eye Doctors in Ardmore, PA
Welcome to your Ardmore Pearle Vision located conveniently in Suburban Square. We have been providing exceptional quality customer service to the Main Line for over 36 years. We offer the latest styles and trends in brands like Rayban, Oakley, Burberry and Silhouette. Our services range from comprehensive eye exams to contact lens fittings. We are known for offering top-of-the-line products such as Varilux and Pearle brand digital lenses as well as other features such as blue light filtering and polarized prescription sunglasses. We accept most major vision plans such as VSP and Eyemed along with Flexible and Health Savings Accounts. Schedule an appointment today with one of our doctors and let our experienced staff embark on your new path to seeing much clearer! Outside prescriptions are accepted.
Store info
74 Coulter Ave., Ardmore, PA 19003
- 610-896-0610
Store Hours
| Sun | Closed |
| Mon | 10:00 AM - 6:00 PM |
| Tue | 10:00 AM - 6:00 PM |
| Wed | 10:00 AM - 6:00 PM |
| Thu | 10:00 AM - 6:00 PM |
| Fri | 10:00 AM - 6:00 PM |
| Sat | 10:00 AM - 3:00 PM |
Accepted Insurances
We work with most major health and vision plans.
40% off lenses with frame purchase
Print or show in store to redeem.
Save 40% on lenses with frame purchase. Complete pair (frame and lenses) purchase required. Valid prescription required.
Terms & conditions apply

40% off second pair
Print or show in store to redeem.
Buy a complete pair of eyeglasses or prescription sunglasses (frame and lenses) and get a second pair (same prescription, same day) for up to 40% off.
Terms & conditions applyLearn More
Where to Buy Glasses
Discover MoreHow to Choose an Eye Doctor
Discover MoreHow to Tell if Your Child Needs Glasses
Discover MoreDiscover New Styles
ESSILOR® STELLEST® LENSES
Essilor® Stellest® lenses are the first and only FDA market authorized spectacle lens to slow the progression of nearsightedness in children
*Compared to single vision lenses. Results from a prospective, randomized, double-masked, multicenter U.S. clinical trial in myopic children aged 6-12 years at initiation of treatment.

















